Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (66.7%)
N/A1 (33.3%)

Trials by Status

completed250%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_3

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

NCT07227246
completed

Recombinant Factor VII for Intractable Postpartum Haemorrhage

NCT05298826
completedphase_3

Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

NCT00243243
unknownnot_applicable

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

NCT01538160

Clinical Trials (4)

Showing 4 of 4 trials
NCT07227246Phase 3

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Recruiting
NCT05298826

Recombinant Factor VII for Intractable Postpartum Haemorrhage

Completed
NCT00243243Phase 3

Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

Completed
NCT01538160Not Applicable

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4